Related references
Note: Only part of the references are listed.Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial
Jaime Soto et al.
CLINICAL INFECTIOUS DISEASES (2019)
Topical paromomycin for New World cutaneous leishmaniasis
Nestor Sosa et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis
Andrea K. Boggild et al.
JOURNAL OF TRAVEL MEDICINE (2019)
Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
Michal Solomon et al.
EMERGING INFECTIOUS DISEASES (2019)
Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review
Vincent Mosimann et al.
ACTA TROPICA (2018)
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
Naomi Aronson et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Global burden of cutaneous leishmaniasis
Chante Karimkhani et al.
LANCET INFECTIOUS DISEASES (2017)
Leishmania infections: Molecular targets and diagnosis
Mohammad Akhoundi et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
Romain Guery et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom
Trupti A. Patel et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature
Vincent Mosimann et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014
Johannes Blum et al.
JOURNAL OF TRAVEL MEDICINE (2014)
Leishmaniasis in the Middle East: Incidence and Epidemiology
Nasir Salam et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama
Nestor Sosa et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy
G. Morizot et al.
CLINICAL INFECTIOUS DISEASES (2013)
International Travel by Persons With Medical Comorbidities: Understanding Risks and Providing Advice
Natasha S. Hochberg et al.
MAYO CLINIC PROCEEDINGS (2013)
Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
Afif Ben Salah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis
Piero Olliaro et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Short Report: Epidemiology of Imported Cutaneous Leishmaniasis at the Hospital for Tropical Diseases, London, United Kingdom: Use of Polymerase Chain Reaction to Identify the Species
Emma C. Wall et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis
Johannes Blum et al.
INTERNATIONAL HEALTH (2012)
Mucosal Leishmania infantum leishmaniasis: Specific pattern in a multicentre survey and historical cases
Benoit Faucher et al.
JOURNAL OF INFECTION (2011)
WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study
Afif Ben Salah et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Marring Leishmaniasis: The Stigmatization and the Impact of Cutaneous Leishmaniasis in Pakistan and Afghanistan
Masoom Kassi et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Share Paper
